HighMark Wealth Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.13M Buy
903,082
+161,600
+22% +$304K 0.46% 31
2025
Q4
$1.77M Buy
741,482
+431,200
+139% +$1.18M 0.72% 21
2025
Q3
$884K Buy
310,282
+145,532
+88% +$498K 0.39% 34
2025
Q2
$621K Buy
164,750
+163,500
+13,080% +$643K 0.3% 42
2025
Q1
$5.66K Hold
1,250
﹤0.01% 357
2024
Q4
$8.84K Hold
1,250
0.01% 302
2024
Q3
$10.2K Hold
1,250
0.01% 297
2024
Q2
$7.99K Hold
1,250
﹤0.01% 322
2024
Q1
$9.41K Hold
1,250
0.01% 287
2023
Q4
$11.6K Hold
1,250
0.01% 247
2023
Q3
$12.7K Hold
1,250
0.01% 234
2023
Q2
$15.6K Hold
1,250
0.01% 206
2023
Q1
$14.6K Hold
1,250
0.01% 243
2022
Q4
$13.3K Hold
1,250
0.01% 215
2022
Q3
$12K Buy
1,250
+1,000
+400% +$13.2K 0.01% 218
2022
Q2
$4K Hold
250
﹤0.01% 373
2022
Q1
$7K Hold
250
﹤0.01% 320
2021
Q4
$10K Sell
250
-395
-61% -$18K 0.01% 255
2021
Q3
$32K Buy
645
+54
+9% +$2.94K 0.02% 144
2021
Q2
$33K Sell
591
-142
-19% -$7.57K 0.02% 147
2021
Q1
$34K Sell
733
-183
-20% -$8.86K 0.03% 129
2020
Q4
$40K Sell
916
-1,012
-52% -$37.3K 0.03% 108
2020
Q3
$71K Buy
1,928
+1,413
+274% +$48K 0.06% 85
2020
Q2
$15K Buy
+515
New +$14.2K 0.02% 161

Other funds holding HCAT